ALS Alert mastheadALS Alert mastheadFall 2005 - Science. Scope. Speed.

ALS Center Web Site
Research
People and Events

In This Issue:

Wanted: A Therapy That Knows No Barrier
Scott Banta says small peptides may do the trick.

When Research Gets Personal
This summer, an unusual twosome worked together in a Packard Center lab.

RESEARCH UPDATE:

Searching for the Mouse that Roars
Why more is better when it comes to ALS mimics.

 

Available Issues:

Winter 2001/2002
Fall 2002
Spring 2003
Fall 2003
Spring 2004
Fall 2004
Winter 2005
Spring/Summer 2005
Fall 2005
Winter 2006

About ALS Alert


When Research Gets Personal

This summer, an unusual twosome worked together in a Packard Center lab at The Johns Hopkins Hospital. One was a high school intern; the other, a young neurologist on a research scholarship from Turkey. Both have been touched by ALS. Two teachers in student Katherine (Kat) Yi’s hometown have the disease. For researcher Oguz Gozen, it’s even more personal: His mother has ALS.

High school intern Kat Yi, left, assisting neurologist Oguz Gozen.

High school intern Kat Yi, left, assisting neurologist Oguz Gozen. “Having a mother with the disease pushes me to work harder,” he says.
PHOTO: BRYAN HORAN

Kat Yi got a firsthand introduction to the Center in June 2004 when she and a busload of students arrived from Northport, N.Y., with a check for $32,000—funds they had raised to honor their teachers. During a tour of the labs, Center Director Jeffrey Rothstein offered to mentor a student with a strong science aptitude. Kat, a stellar student who hopes to become a surgeon, was selected.

Fortunately, she was paired with mentor Gozen, whose will to cure ALS drives his work. As Gozen recalls, his mother’s ALS began with an unexplainable limp. At first her doctor thought she had multiple sclerosis. But when doctors diagnosed “motor neuron disease,” Gozen, then a medical student doing a rotation in the department of neurology, knew immediately they were using a euphemism for ALS.

Gozen seeks ways to protect key spinal cord neurons before ALS’s damage begins. He is also involved in NIH-sponsored translational research for ALS therapies. Research scholarships have taken him to labs all over Europe, but none, he says, compares with Hopkins. “Here you have resources, equipment and people to bounce ideas off of constantly.”

He will eventually return to his post at the Aegean University School of Medicine in Turkey.

Next > Searching for the Mouse that Roars
Why more is better when it comes to ALS mimics.


Sign up for ALS news, the print version of the newsletter and more:
   

Special Features:

Vantage Point
After a decade with riluzole, the single approved drug that neither stops nor reverses the disease, we in the ALS research community are doing serious soul-searching.

On Center
Like Family

A Friend Indeed
Lessons in Loyalty

The Big Board
Kindred Spirits

Make a Donation


Johns Hopkins Medicine
© Copyright 2005 | All Rights Reserved | Robert Packard Center for ALS Research at Johns Hopkins
600 N. Wolfe Street, Meyer 6-109, Baltimore, Maryland 21287-5953 USA
Site Index Frequently Asked Questions Contact Us Hopkins Medicine